Tech Company Financing Transactions

Constellation Pharmaceuticals Funding Round

SR One Capital Management, Altitude Life Science Ventures and The Column Group invested in a $22 million Series B funding round for Constellation Pharmaceuticals. The funding round was announced by the company on 6/2/2010.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

215 First St. 200
Cambridge, MA 02142
USA

Phone

(617) 714-0555

Website

www.constellationpharma.com

Email Address

[email protected]

Overview

Constellation Pharmaceuticals (Nasdaq: CNST) is the leading biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of epigenetics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jigar Raythatha

        

Chief Financial Officer

Emma Reeve

        

Chief Medical Officer

Adrian Senderowicz

        

Vice President

Patrick Trojer

        

VP - Bus. Development

Brad Prosek

        

VP - Human Resources

Brenda Sousa

        

Browse more venture capital transactions:

Prev: 6/2/2010: Snapfinger venture capital transaction
Next: 6/3/2010: HauteLook venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary